AstraZeneca

AstraZeneca’s Imfinzi gets FDA priority review for small cell lung cancer

Read more

US FDA approves AstraZeneca’s diabetes drug for treating heart failure risk

Read more

We have unlocked the potential of data in the DMTA cycle

Read more

AstraZeneca India receives marketing permission for QTERN

Read more

AstraZeneca lupus drug shows promise after set-back last year

Read more

US FDA grants orphan drug status to AstraZeneca’s asthma drug Fasenra

Read more

FDA gives fast track status to AstraZeneca’s diabetes drug Farxiga

Read more

AstraZeneca’s Farxiga meets main goal of heart failure study

Read more

AstraZeneca’s Tagrisso helps lung cancer patients live longer: study

Read more

Chennai will house more than 60 per cent of AstraZeneca’s global IT workforce

Read more